Coronavirus / COVID

Latest News

Moderna Withdraws BLA For its Influenza COVID-19 Combination Vaccine
Moderna Withdraws BLA For its Influenza COVID-19 Combination Vaccine

May 21st 2025

The company made the decision after the FDA requested more vaccine data for the mRNA-1083 vaccine. Moderna plans to resubmit their Biologics License Application (BLA) for the vaccine later this year.

FDA Shifts COVID-19 Vaccine Policy, Requires Further Testing
FDA Shifts COVID-19 Vaccine Policy, Requires Further Testing

May 21st 2025

FDA Approves Novavax COVID-19 Vaccine
FDA Approves Novavax COVID-19 Vaccine

May 19th 2025

Investigational Long COVID Therapy Enrolls First Phase 2 Participant
Investigational Long COVID Therapy Enrolls First Phase 2 Participant

May 15th 2025

Influenza COVID-19 Combination Vaccine Induces Higher Immune Response Than Standalone Immunizations
Influenza COVID-19 Combination Vaccine Induces Higher Immune Response Than Standalone Immunizations

May 7th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.